Clinical Trial Update: Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating the efficacy and safety of BMSCs (CG-BM1) for acute-on-chronic liver failure, currently in Phase 1/2 and recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• BMSCs CG-BM1

Snippet

Sponsor: Sun Yat-sen University | Conditions: Acute-On-Chronic Liver Failure | Phase 1, Phase 2 | Status: RECRUITING